SCRI Research Symposium
Office for Teaching, Education and Research (OTER) at Seattle Children's Research Institute
5th Annual Research Symposium for postdocs and students at Seattle Children's Research Institute.
For those who don't have independent zoom links, please connect via this link:
https://us02web.zoom.us/j/81010577982?pwd=TTB1d2ZhQnlUdUVXWTlyU2hsdmsvdz09
More info: https://scriresearchsymposium
Filter displayed posters (11 keywords)
Modeling kinase networks involved in peroxisome biogenesis via single-cell colocalization and morphology metrics
Therese M. Pacio, Fred D. Mast, and John D. Aitchison
Association between eyes closed resting state alpha EEG power and social responsiveness in youth with and without ASD: The GENDAAR Study
Milana Premkumar, Megha Santhosh, MHA, Kevin Pelphrey, PhD, Sara Jane Webb, PhD, Emily Neuhaus, PhD, & the GENDAAR Consortium
Siglec 9 is expressed on human mast cells and decreases their inflammatory potential
Irina Miralda, PhD; Nyssa B. Samanas, PhD; Adrian M. Piliponsky, PhD
A New Path for CF Clinical Trials through the Use of Historical Controls
Mark Warden, MS, Amalia S. Magaret, PhD, Noah Simon, PhD, Sonya Heltshe, PhD, George Z. Retsch-Bogart, MD, Bonnie W. Ramsey, MD, Nicole Mayer-Hamblett, PhD
Methods: The study included data from sequentially completed, randomized, controlled clinical trials, EPIC and OPTIMIZE respectively, evaluating optimal antibiotic therapy to reduce the risk of pulmonary exacerbation in children with early Pseudomonas aeruginosa infection. EPIC and OPTIMIZE both enrolled CF children with new onset Pa having similar eligibility criteria. The primary treatment effect in OPTIMIZE, the risk of pulmonary exacerbation associated with azithromycin, was re-estimated in alternative designs incorporating varying numbers of participants from the earlier trial (EPIC) as historical controls. The historical controls were incorporated using: (1) Pooling: combining all available participants from both studies to increase the size of the OPTIMIZE control group, (2) Augmenting: omitting half the OPTIMIZE participants randomized to placebo and augmenting the OPTIMIZE control group with all EPIC historical controls, (3) Replacing: omitting all OPTIMIZE participants randomized to placebo and replacing with all EPIC historical controls. Bias and precision of these estimates were characterized. Propensity scores were derived to adjust for baseline differences across study populations, and both Poisson and Cox regression used to estimate treatment efficacy.
Results: To standardize eligibility for this study, subjects <1 year of age and >12 were removed from OPTIMIZE. Baseline characteristics of the two study populations were otherwise largely similar. There were some notable differences, however: OPTIMIZE participants were more likely to chronically use hypertonic saline (35.6% vs 4.3%), and modulators (10.5% vs 0.0%) due to the timing of the trial in relation to changing standard of care. A propensity score for study of origin was computed, which correctly classified 75% to 84% of participants, depending on method of incorporating controls. In the original OPTIMIZE trial, there was a significant 44% reduction in risk of PEx associated with azithromycin as compared to placebo. Replacing 86 OPTIMIZE placebo participants with 304 controls from EPIC to mimic a fully historically controlled trial resulted an 8% reduction in risk of pulmonary exacerbations (HR:0.92 95% CI 0.61, 1.34) when not adjusting for key baseline differences between study populations. After adjustment, a 37% decrease in risk of exacerbation (HR:0.63, 95% CI 0.50,0.80) was estimated, comparable to the estimate from the original trial.
Conclusions: The potential exists for future CF trials to utilize historical control data. Careful consideration of the comparability of controls and optimal can reduce the potential for biased estimation of treatment effects.
Disparities in Access to Telehealth Services Among Gender Diverse Adolescents: Assessment of Seattle Children’s Gender Clinic Telehealth Visits
Ruby Lucas, MPH, Nicole Kahn, PhD, MEd, Kevin Bocek, BA, Diana Tordoff, MPH, Baer Karrington, MD, MScPH, Laura Richardson, MD, MPH, Gina Sequeira, MD, MS
Evaluating the Feasibility and Acceptability of Using Ecological Momentary Assessment For Psychiatric Services During the COVID-19 Pandemic
Yesenia Garcia, B.A., Cindy Ola, PhD, Brent Collett, PhD, Freda Liu, PhD
Hypothesis: We hypothesize that EMA will be a feasible and acceptable method for use in outpatient psychiatry groups.
Methods: Spanish and English-speaking parents and their children who were enrolled in 1 of 6 outpatient psychiatry groups at Seattle Children’s North Clinics were invited to participate in the study. After informed consent was obtained, participating families downloaded the Metric Wire application, designed for EMA data collection. Families received EMA notifications to complete a survey between 2-3 times per week on either a specified time designated by the participants or on randomly selected days throughout the week. EMA questions asked about the child’s mood, behavior or a specific parenting skill used on a particular day. Participating families and clinicians completed semi-structured qualitative interviews to obtain feedback about the acceptability of these procedures as part of outpatient psychiatric care.
Results: 15 families enrolled in the study. 47% of participants were Caucasian, 33% were Hispanic, and 20% were Asian/Pacific Islander. 27% of participants were primarily Spanish-speaking families. On average, families responded to 55% of EMA surveys. Based on the qualitative interviews, participating families reported that each EMA survey served as a “reminder” to utilize one of the parenting skills taught in their outpatient group. Based on qualitative interviews with clinicians, they expressed difficulty in incorporating EMA as part of their outpatient psychiatry group. Challenges centered around the time-commitment and remembering to review the EMA surveys for each family participating in the study.
Conclusions: Preliminary data indicates that EMA is acceptable to families but there are issues with feasibility that may pose a challenge for integration in outpatient psychiatry services. Our findings will provide recommendations for overcoming feasibility challenges and recommendations for future iterations of EMA procedures in clinical care.
Ki67, CXCR3, and CCR6 antibody labeling of hepatic T cells in naïve and SIV-infected macaques
Yohannes M. Abraham, Katherine A. Fancher, Nina Derby, PhD, Donald Sodora, PhD
Methods: Liver biopsies from rhesus macaques were fluorescently labeled for CD3 (T cell), Ki67, CXCR3, and CCR6 antibodies. CD3+ Ki67+ cells were analyzed in naïve and SIV+ animals at baseline (week 4 before infection) and acute/early infection (week 2 after infection). Both CD3+ CXCR3+ and CD3+ CCR6+ cells were investigated at acute infection and necropsy (week 15-32 after infection). Immunofluorescence analysis was performed with Keyence BZ-X710 microscope. Computational analysis was conducted using Fiji/Image J, to quantify the percentage of hepatic Ki67+, CXCR3+, and CCR6+ T cells. GraphPad Prism was used to plot the results and perform statistical analyses.
Results: During acute SIV infection, the expression of Ki67+ T cells in all SIV-infected macaques was significantly higher than at baseline (P< 0.0001) and in naïve samples (P< 0.0001). Two SIV-infected macaques had a greater proportion of CXCR3 at necropsy compared to week 2, while two other SIV-infected macaques showed the opposite trend. In the CCR6+ subset, the same relationship was observed, however not for corresponding animals. Overall, comparing week 2 and necropsy, in the SIV cohort there was no significant change of expression of both CXCR3+ and CCR6+ T cells. At week 2 and necropsy, CXCR3+ T cells averaged 45% and 40%, respectively, whereas CCR6+ T cells averaged 10% and 11%, respectively.
Conclusion: Our findings indicate that hepatic T cell replication in SIV-infected macaques increases in early infection compared to baseline and in naïve samples. Contrary to our hypotheses, there was not a significant difference in the proportion of hepatic T cells expressing CXCR3 and CCR6 early and at late stage SIV infection. Further investigation will assess CXCR3+ and CCR6+ T cells at baseline and intermittent timepoints between week 2 and necropsy. In addition, more research will quantify CXCR3+ and CCR6+ T cells within the CD4+ and CD8+ T cell populations.
Attitudes and Engagement: The Use of AI Feedback and an Online Office for Treating ADHD Patients
Jessica M. Monroy, Sibley H. Margaret, PhD
Digital Health Equity
Jordyn Warner and Arti Dilip Desai, MD, MSPH
Conclusion/Discussion: Health information technologies are an ongoing issue in healthcare. Further methods of reducing these issues need to be put in place to break down this barrier to promote equity within hospitals.
Assessment of follow-up rates after urinary incontinence diagnoses in pediatric populations
Taylor Washington and Kathleen Kieran MD, MSc, MME
Materials and Methods: We compiled data from January 2017-March 2017 and January 2018-March 2018 in a retrospective medical review of outpatients seen through the Seattle Children’s healthcare network. Demographic information, voiding concerns, and percentage of follow up rates within the time frames given by providers were assessed. Data was analyzed using SAS version 9.3 (Cary, NC). Findings were considered statistically significant at p<0.05.
Results: Patients who used an interpreter and had a long distance to travel for follow up were unlikely to return to the clinic within their clinically suggested time frame. Patients at or below the poverty level had statistically significantly different follow up rates when compared to patients of higher incomes regardless of diagnoses. Odds ratio of Black patients being told to return for scheduled follow-up versus white patients: 7.3 (95% CI: 1.3, 40.0); for Asian patients vs white 1.75 (0.39, 7.9), for American Indian patients versus white 2.4 (0.12-48.0). Odds ratio of patients with LOE being told to return for follow up compared with English-speaking patients: 1.54 (0.57-42). If given appointment recommendation, patient was 6.2 times as likely to return for follow-up visit (2.1, 12.5). None of the Black patients who were told to follow-up as needed followed up at all, whereas 19.2% of the white patients did. Of patients told to follow up, 80% of white patients did and 100% of Black patients did.
Conclusions: Race affected follow up rates for patients who visited the urology clinic. Specific recommendations from providers for follow up also led to increased rates of follow up at recommended rate times regardless of race or diagnoses. Further research should include a larger demographic of patients over a longer period of time.
Targeted Ndufs4 KO in PV interneurons is sufficient to produce a mild LS-related epilepsy phenotype in mice
Devika Gandhay, Arena Manning, Elizabeth Chen, Rainelle Nevers, Franck Kalume PhD
Hypothesis: We hypothesized that since PV interneurons display fast spiking patterns, the Ndufs4 KO will impair these cells, leading to severe spontaneous seizures, cell loss, and neurocognitive impairments.
Methods: Experimental mice models with Ndufs4flx/flx/PVCreflx/+ genotype for the mutants, and Ndufs4flx/flx/PVCre+/+ genotype for the controls were used in all of the experiments except imaging. For imaging experiments, Ndufs4flx/flx/Ai14flx/+/PVCreflx/+ were used for mutants and Ndufs4+/+/Ai14flx/+/PVCreflx/+ were used for controls.
For open field, mice of both genotypes were placed into a 50x50 cm open field chamber for 10 minutes and their movements were tracked. For EEG recordings, mice were implanted with EEG/EMG electrodes and placed in recording chambers where we assessed occurrence, frequency and duration of seizures and epileptiform events. For the PTZ challenge, mice were injected (subcutaneous) with 20 mg/kg PTZ and then placed in recording chambers for approximately 30 minutes where we assessed occurrence, frequency, and duration of seizures. For imaging, we counted Ai14-labeled PV interneurons in key areas associated with epilepsy (for example, cortex and hippocampus) between the two groups. Brains were harvested, sliced, mounted in triplicates, and imaged at 10X with a confocal microscope.
Results: PV mutants showed an increase in the frequency of myoclonic seizures and interictal spikes. There was no difference in seizure susceptibility (from the PTZ challenge) between mutants and controls. Additionally, we did not observe major impairments in locomotor activity nor anxiety like behavior in PV mutants. Finally, we did not detect cell loss changes in PV mutants.
Conclusion: These experiments show that PV mutants display a mild seizure phenotype, with no cognitive or motor abnormalities, suggesting targeted Ndufs4 KO in PV interneurons does not drive the severe epilepsy phenotype in LS.
Robotic Mosquito Dissection to Accelerate Malaria Research
Zephyr Pitre, Tess Seltzer, Christopher Sutanto, Samantha L. Brown, Thurston Herricks, Kamalakannan Vijayan, Veronica Primavera , Mikaela Follmer, Elizabeth K.K Glennon, Natasha Bourgeois, Scott E. Lindner, John D. Aitchison, Alexis Kaushansky